Abstract:Capital.com South Africa licence bid highlights growth as CFD brokers in South Africa compete for ODP approval.

Capital.com has applied for a South African licence and is seeking to expand its presence in the country by complying with local regulatory requirements, including the OTC Derivatives Products (ODP) licence mandatory for CFD brokers operating in South Africa. The broker is part of a broader trend of CFD brokers entering the South African market, which is overseen by the Financial Sector Conduct Authority (FSCA). With a focus on compliance, transparency, and client support, Capital.com aims to establish a regulated and trusted offering for South African traders.
Capital.com recently applied for a South African licence as part of its global expansion strategy, aiming to include South Africa among the markets where it offers regulated CFD products. The company, already authorised in regions such as the UK, Australia, and the UAE, is investing in infrastructure and technology to meet the highest regulatory standards expected in South Africa. While specific product launches remain unconfirmed, the broker‘s intention is to ensure compliance with the FSCA’s rules and focus on transparency and client service.

South Africa has become an attractive region for CFD brokers, requiring firms to obtain an OTC Derivatives Products (ODP) licence to legally operate. Several brokers, including EBC Financial, Mitrade, and Monaxa, have obtained the ODP licence recently, a must-have for entities offering CFDs and other OTC derivatives as principals. The FSCA regulates this market, ensuring firms adhere to strict conduct and client protection standards. Despite the opportunity, some brokers like IG Group have withdrawn, citing different market assessments.
The OTC Derivatives Products licence is essential for brokers conducting over-the-counter derivatives business in South Africa. It authorises entities to originate, issue, or sell OTC derivatives—including CFDs—and ensures these providers are regulated by the FSCA under the Financial Markets Act 2012. Without this licence, operating legally in South Africa's OTC derivatives market is prohibited. The application process is rigorous, underlining the regulatory commitment to market integrity and investor protection.
Capital.com's move to secure its South African licence reflects a strategic effort to capitalize on this dynamically growing market by delivering regulated CFD products and related services to South African traders, reinforcing trust and compliance in this sector.


Concerned about ForexDana? Explore recent scam reports and the dangers of unregulated ForexDana broker trading. Protect your investments – read our review now!

Axiory is a trading company that started in 2012. It says it offers different ways to trade with easy-to-use platforms. The company has been around for around 15 years and tries to attract traders by promising low starting amounts and high leverage. However, when we look more closely at this broker, we find some serious problems. WikiFX, a website that checks trading companies around the world, gave Axiory a very low score of only 2.45 out of 10. This low score is based on real data and shows that there are major issues with this company. This review takes a deep look at why Axiory got such a bad rating. We will examine how well the company is regulated, look at real complaints from users, and check their trading rules. Our goal is to give traders the facts they need to make a safe choice, especially since there is a clear "High potential risk" warning about this broker.

Discover the truth in our MONAXA review. With no valid regulation and rising 2025 scam cases, learn why you must avoid MONAXA login and trading.

Worried about PURPLE TRADING’s safety? Read our 2026 review to uncover recent WikiFX alerts, regulation details, and key broker insights before you trade. Stay informed and protect your Forex investments—read the full review now!